Vnitr Lek 2016, 62(Suppl 6):25-29

Plasma and salivary markers of oxidative and carbonyl stress in patients with acute intermittent porphyria

Miroslav Mydlík1,2,*, Katarína Derzsiová1, Ivana Koborová3, Katarína Šebeková3
1 IV. interná klinika LF UPJŠ v Košiciach a UN L. Pasteura Košice, Slovenská republika
2 Ústav experimentálnej medicíny LF UPJŠ v Košiciach, Slovenská republika
3 Ústav molekulárnej biomedicíny LF UK v Bratislave, Slovenská republika

Background:
Acute intermittent porphyria (AIP) is an autosomal inherited disease caused by deficiency of the third enzyme in the heme biosynthetic pathway, porphobilinogen deaminase. The clinical course of the disease is characterized by acute attacks, most often with abdominal pain.


The aim of our study was to investigate selected markers of oxidative and carbonyl stress in plasma and saliva in patients with AIP and to find out whether saliva could be used for monitoring the disease progression. Saliva is an attractive biological fluid for determination of biochemical markers in various pathological conditions. The advantage is that saliva can be collected non-invasively, and the examination needs only a small volume of saliva.

Methods:
Blood and total non-stimulated saliva were collected from 16 patients with AIP in remission, and from 20 healthy individuals. Markers of oxidative and carbonyl stress - advanced glycation end products (AGEs), and thiobarbituric acid reacting substances (TBARS) were determined by spectrofluorometric methods, advanced oxidation protein products (AOPPs), total antioxidant capacity (TAC) and ferric reducing ability of plasma/saliva (FRAP/FRAS) were investigated by spectrophotometric methods in the above mentioned groups.

Results:
Advanced glycation end products and thiobarbituric acid reacting substances in plasma and saliva were significantly higher in patients with AIP in comparison to the control group (p < 0.001) and (p < 0.05). Advanced oxidation protein products in AIP if compared to the control group did not show statistical significance (p > 0.05), but the levels in the saliva were significantly lower (p < 0.001). The concentrations of markers of antioxidant status of plasma and saliva were significantly lower in AIP if compared to the control group (p < 0.001).

Conclusions:
According to the best of our knowledge this is the first study to demonstrate increased concentrations of markers of oxidative and carbonyl stress and decreased antioxidant status of plasma and saliva in patients with AIP. Moreover, the study suggests that the saliva might be a promising fluid to study relevant biomarkers in a wide array of human biomedical conditions.

Keywords: acute intermittent porphyria; biomarkers; oxidative and carbonyl stress; plasma and saliva

Received: August 16, 2016; Accepted: September 26, 2016; Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mydlík M, Derzsiová K, Koborová I, Šebeková K. Plasma and salivary markers of oxidative and carbonyl stress in patients with acute intermittent porphyria. Vnitr Lek. 2016;62(Supplementum 6):25-29.
Download citation

References

  1. Besur S, Schmeltzer P, Bonkovsky HL. Acute porphyrias. J Emergency Med 2015; 49(3): 305-312. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jemermed.2015.04.034>. Go to original source... Go to PubMed...
  2. Mydlík M, Derzsiová K, Legáth Ľ et al. Klinické a biochemické poruchy pri akútnej intermitentnej porfýrii a porfýrii variegata. Interná Med 2016; 16(2): 58-62.
  3. Ventura P, Capellini MD, Rocchi E. The acute porphyrias: a diagnosis and therapeutic chalenge in internal and emergency medicine. Int Emerg Med 2009; 4(4): 297-308. Dostupné z DOI: <http://dx.doi.org/10.1007/s11739-009-0261-4>. Go to original source... Go to PubMed...
  4. Sardh E, Harper P, Andersson Dan EH et al. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks. Europ J Intern Med 2009; 20(2): 201-207. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ejim.2008.06.012>. Go to original source... Go to PubMed...
  5. Kamodyová N, Tóthová Ľ, Celec P. Salivary markers of oxidative stress and antioxidant status: Influence of external factors. Disease Markers 2013; 34(5): 313-321. Dostupné z DOI: <http://dx.doi.org/10.3233/DMA-130975>. Go to original source... Go to PubMed...
  6. Wang J, Schipper HM, Velly AM et al. Salivary biomarkers of oxidative stress: A critical review. Free Radic Biol Med 2015; 85: 95-104. Dostupné z DOI: <http://dx.doi.org/104.10.1016/j.freeradbiomed.2015.04.005>. Go to original source... Go to PubMed...
  7. Karlík M, Valkovič P, Hančinová V et al. Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis. Clin Biochem 2015; 48(1-2): 24-28. Dostupné z DOI: <http://dx.doi.org/10.1016/j.clinbiochem.2014.09.023>. Go to original source... Go to PubMed...
  8. Peluso I, Raguzzini A. Salivary and urinary total antioxidant capacity as biomarkers of oxidative stress in humans. Patholog Res Int 2016; 2016: 5480267. Dostupné z DOI: <http://dx.doi.org/10.1155/2016/5480267>. Go to original source... Go to PubMed...
  9. Mydlík M, Derzsiová K, Javorská K et al. Markery oxidačného a karbonylového stresu u hemodiafiltrovaných chorých. Interná Med 2015; 15(7-8): 324-328.
  10. Mauzeral D, Granick S. The occurrence and determination of δ-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 1956; 219(1): 435-446. Go to original source... Go to PubMed...
  11. Kyselina 5-aminolevulová (ALA) / Porfobilinogén(PBG). Chromatografia - spektrofotometria. Biosystems Reagents & Instruments. Slovenský preklad: 2016. Dostupné z DOI: <http://www.jktrading.cz/mbfile-11017-ala-pbg-1505.pdf>
  12. Münch G, Keis R, Wesels A et al. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem 1997; 35(9): 669-677. Go to original source... Go to PubMed...
  13. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49(5): 1304-1313. Go to original source... Go to PubMed...
  14. Anderstam B, Ann-Christin BH, Valli A et al. Modification of the oxidative stress biomarker AOPP assay: application in uremic samples. Clin Chim Acta 2008; 393(2): 114-118. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cca.2008.03.029>. Go to original source... Go to PubMed...
  15. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996; 239(1): 70-76. Go to original source... Go to PubMed...
  16. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37(4): 277-285. Go to original source... Go to PubMed...
  17. Behuliak M, Palffy R, Gardlik R et al. Variability of thiobarbituric acid reacting substances in saliva. Dis Markers 2009; 26(2): 49-53. Dostupné z DOI: <http://dx.doi.org/10.3233/DMA-2009-0606>. Go to original source...
  18. Mydlík M, Derzsiová K, Jenča A et al. Kyselina oxalová a askorbová v slinách pri chronickej renálnej insuficiencii. Akt Nefrol 2006; 12(2): 41-44. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.